Drug Screening

The Air Force District of Washington, Contracting Directorate (AFDW/PK) is conducting market research to identify vendors capable of providing civilian drug testing services for the United States Space Force (USSF) Drug Screening program. The procurement encompasses specimen collection services, facilitation of specimen collection, and Medical Review Officer (MRO) support services, with the contract structured as Firm-Fixed-Price (FFP) under NAICS code 621511 (Medical Laboratories). Key requirements include compliance with HIPAA regulations, submission of monthly status reports by the 10th calendar day, participation in a kick-off meeting within 10 business days of contract award, and quarterly virtual Program Management Reviews. The government seeks vendors with demonstrated experience in government civilian drug screening programs and military service organizations, with all prospective contractors required to be registered in the System for Award Management (SAM) database. The original deadline for vendor responses was January 20, 2026, at 2:00 PM EST, though this was extended via Amendment 01 to February 13, 2026, to allow adequate time for vendors to submit their sources sought responses. Amendment 02, posted on February 10, 2026, provided government responses to vendor questions regarding service scope and requirements.

This procurement carries no set-aside designation and is open to both large and small businesses, with the small business size standard identified as $41.5M. The estimated contract volume includes approximately 1,500 urine samples collected annually from civilian employees across all U.S. locations, with samples subsequently mailed to Department of Air Force-approved laboratories for analysis. The contract structure includes a base year of 12 months with four optional 12-month extensions, and contractor billing will occur monthly for actual sample collections. Testing will follow DAF-approved standards for civilian drug screening panels and will be administered at DAF-approved laboratories nationwide, positioned in proximity to candidate locations. The scope is expressly limited to specimen collection only, excluding laboratory analysis, sample testing, and confirmation testing functions, which remain the responsibility of DAF-approved laboratories. No incumbent contractor information has been disclosed in the pre-solicitation materials, and no specific budget range has been publicly announced at this market research stage.